# AstraZeneca Nijmegen B.V., Nijmegen, Netherlands – FDA Inspections

Source: https://www.keypedia.com/companies/astrazeneca-nijmegen-bv/29dc14a3-b8e5-4e0a-9399-8d18afc9d686

> Inspection records and compliance data for AstraZeneca Nijmegen B.V. in Nijmegen. 8 FDA inspections on record, 2 Form 483s, last inspected April 10, 2024.

---

## Details

- Name: AstraZeneca Nijmegen B.V.
- FEI Number: 3003000472
- Address Line 1: Lagelandseweg 78
- City: Nijmegen
- Country Name: Netherlands
- Address: Lagelandseweg 78, Nijmegen, Netherlands
- Country: Netherlands

## Related Documents

- FDA Inspection 1276715 - AstraZeneca Nijmegen B.V. - 2024-04-10 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 10, 2024
- [483 - AstraZeneca Nijmegen B.V. - 2019-09-19](https://www.keypedia.com/records/483/astrazeneca-nijmegen-bv/cfae0374-c679-4edd-9838-4f8b3339c100) — source: FDA, date: September 19, 2019
- [FDA Inspection 1107865 - AstraZeneca Nijmegen B.V. - 2019-09-19](https://www.keypedia.com/records/fda_inspections/astrazeneca-nijmegen-bv/667f00c6-5bc5-4294-9344-bac4026e531a) — source: FDA, date: September 19, 2019
- FDA Inspection 1112441 - AstraZeneca Nijmegen B.V. - 2019-09-10 — classification: No Action Indicated (NAI), source: FDA, date: September 10, 2019
- [FDA Inspection 1036241 - AstraZeneca Nijmegen B.V. - 2017-09-22](https://www.keypedia.com/records/fda_inspections/astrazeneca-nijmegen-bv/6972f213-31aa-4ac1-99aa-f1eef33a7a0c) — source: FDA, date: September 22, 2017
- [FDA Inspection 936026 - AstraZeneca Nijmegen B.V. - 2015-06-05](https://www.keypedia.com/records/fda_inspections/astrazeneca-nijmegen-bv/431aceeb-f51b-4582-9cbb-06d8dae48230) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 5, 2015
- FDA Inspection 850854 - AstraZeneca Nijmegen B.V. - 2013-06-21 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 21, 2013
- FDA Inspection 757334 - AstraZeneca Nijmegen B.V. - 2011-09-27 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 27, 2011
- FDA Inspection 548265 - AstraZeneca Nijmegen B.V. - 2008-10-23 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 23, 2008

## Related Companies

- [Takeda GmbH, Plant Oranienburg](https://www.keypedia.com/companies/takeda-gmbh-plant-oranienburg/c72ad117-1d9b-474a-8d1a-c4d0e81e9ba8)
- [Glenmark Pharmaceuticals Limited](https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/dacc6330-129c-4ce4-8c41-f71525daebe5)
- [Thymoorgan Pharmazie Gmbh](https://www.keypedia.com/companies/thymoorgan-pharmazie-gmbh/b58b84eb-57d4-4730-8fbb-58632f71023d)
- [Alphapharm Pty, Ltd.](https://www.keypedia.com/companies/alphapharm-pty-ltd/9007b3c5-9b83-4783-b65d-52eb0246708e)
- [Watson Pharma Private Limited](https://www.keypedia.com/companies/watson-pharma-private-limited/846d9c2f-be10-415a-b681-5436e078ebfd)
- [Bora Pharmaceuticals Laboratories, Inc](https://www.keypedia.com/companies/bora-pharmaceuticals-laboratories-inc/9bb86ed9-7d7d-4886-a145-b9497462c295)
- [Patheon Inc.](https://www.keypedia.com/companies/patheon-inc/76561a83-edb8-4c76-934b-6b2bd5e67949)
- [Lantheus Medical Imaging, Inc.](https://www.keypedia.com/companies/lantheus-medical-imaging-inc/6e9954f9-4df0-41b8-bad7-e8117a91ef76)
- [Cadila Pharmaceuticals Limited](https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/ea4ece29-89c9-42f3-9afa-58348dc605b9)
- [IBSA Institut Biochimique SA](https://www.keypedia.com/companies/ibsa-institut-biochimique-sa/b4d0cf36-d7bc-4ea3-851a-9b0efe59255e)

## Related Officers

- [ Investigator, Consumer Safety Officer](https://www.keypedia.com/people/thuy-t-nguyen/1cfb5467-f0b7-49b8-85c1-00373692e35e)
